Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ditropan XL Patent Invalid; J&J Petition Last Obstacle To ANDA Approvals

Executive Summary

A Johnson & Johnson citizen petition appears to be the only impediment to approval of generic versions of Ditropan XL after a patent for the incontinence therapy was deemed invalid

You may also be interested in...



FDA Approves Generic Of GSK Flonase But Launch Halted By Restraining Order

FDA's approval of generic Flonase has prompted a lawsuit by GlaxoSmithKline representing another challenge by brand manufacturers to the legitimacy of FDA-approved generic drugs

FDA Approves Generic Of GSK Flonase But Launch Halted By Restraining Order

FDA's approval of generic Flonase has prompted a lawsuit by GlaxoSmithKline representing another challenge by brand manufacturers to the legitimacy of FDA-approved generic drugs

Citizen Petition Reform Proposals Include User Fees, Payments For Lost Profits

User fees for citizen petitions may discourage abuse of the process, Sandoz VP-Intellectual Property & Regulatory Shashank Upadhye said Sept. 30 at the Institute for International Research's Annual Generic Drugs Summit in Washington, D.C

Related Content

Topics

UsernamePublicRestriction

Register

PS046376

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel